home / stock / fhlc / fhlc news


FHLC News and Press, Fidelity MSCI Health Care Index ETF

Stock Information

Company Name: Fidelity MSCI Health Care Index ETF
Stock Symbol: FHLC
Market: NYSE

Menu

Get FHLC Alerts

News, Short Squeeze, Breakout and More Instantly...

FHLC - Q2 watchlist: Healthcare stocks with perfect EPS revision scores

2026-07-10 10:52:36 ET More on Health Care stocks Soft Landing Myth: How This Week's Data Exposed The Hidden Recession Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It IXJ: Healthcare Sector Dashboard For June Biotech rally res...

FHLC - Healthcare Investing: Finding Growth Beyond Pharmaceuticals

2026-07-10 02:30:00 ET By Vinay Thapar, CFA & Jane Bleeg Equity investors should cast a wide net to capture the healthcare sector’s full potential. ... Read the full article on Seeking Alpha For further details see: Healthcare Investing: Finding Gr...

FHLC - Biotech rally rests on fundamentals, M&A appetite, says ROTY's Faison

2026-07-09 04:33:52 ET More on Health Care Soft Landing Myth: How This Week's Data Exposed The Hidden Recession Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It AI Revolutionizing Biopharma: Faster, Better, Cheaper Healthcare breadt...

FHLC - Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?

2026-07-05 09:35:01 ET The Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) may appeal to cost-conscious investors seeking broad stability, whereas the State Street SPDR S&P Biotech ETF (NYSEMKT:XBI) targets growth through a narrow, higher-cost focus. Healthcare is...

FHLC - FHLC vs. BBH: Which Healthcare ETF Is the Better Buy?

2026-07-04 07:06:01 ET Choosing between a broad healthcare fund and a focused biotech fund comes down to how much risk -- and potential reward -- an investor is willing to take on. The Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) and the VanEck Biotech ETF (NASDAQ:BBH) ...

FHLC - Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in June 2026

2026-07-01 10:20:46 ET Short interest data from late June 2026 highlights deeply divided investor sentiment across the healthcare sector. Strong bearish bets remain heavily concentrated in speculative biotech plays like Recursion Pharmaceuticals ( RXRX ) and Aditxt ( ADTX ...

FHLC - Most and least shorted mid- to mega-cap healthcare stocks at the end of June

2026-07-01 10:05:32 ET More on the healthcare sector: Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It AI Revolutionizing Biopharma: Faster, Better, Cheaper Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit No...

FHLC - America At 250: Built On Reinvention, Powered By Innovation

2026-07-01 03:20:00 ET By William F. "Ted" Truscott As the United States marks its 250th anniversary, this moment stands as both a milestone and an inflection point. What has defined the U.S. economy over the past two and a half centuries is not continuity, but reinvention - fro...

FHLC - Biotech Is The Rate Cut Trade In Disguise

2026-06-29 17:20:00 ET A week ago, I wrote that leadership had left the mega-cap “generals” and split into two baskets: semiconductors (velocity) and regional banks (breadth). That’s still true. But the dashboard has been quietly flagging a third group climbing the ...

FHLC - Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It

2026-06-29 17:00:00 ET One of the dominant themes in the biopharma industry over the last few years has been the looming patent cliffs that could erase hundreds of billions in annual sales.... Read the full article on Seeking Alpha For further details see: Big Pharma's L...

Next 10